Hepatitis B Foundation calls reports J & J is deprioritizing its hepatitis therapy efforts 'disappointing'

"We entered 2023 with a robust and diverse pipeline of potential treatments for hepatitis B, but this news demonstrates the precarious nature of the pipeline."
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news